Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

Stopped New data; the study was terminated based on new efficacy data from another study

Conditions

• Treatment-resistant Schizophrenia

Interventions

• DRUG: Lu AF35700
• DRUG: Risperidone
• DRUG: Olanzapine

Sponsor

H. Lundbeck A/S